Intraoperative Floppy Iris Syndrome in patients on alpha 1 blocker tamsulosin: incidence and predictability
DOI:
https://doi.org/10.18203/2320-6012.ijrms20202270Keywords:
Alpha 1 blocker drugs, Intraoperative Floppy Iris Syndrome, Miosis, Poor pupil dilation, TamsulosinAbstract
Background: Intraoperative Floppy Iris Syndrome (IFIS) was first described by Chang and Campbell in year 2005 in male patients undergoing phacoemulsification surgery who were on Tamsulosin, an alpha 1 blocker drug for their urinary symptoms for enlarged prostate. This condition was characterized by excessive floppiness of iris, prolapse of iris tissue through phaco and sideport incisions and progressive intraoperative miosis, resulting in increased surgical time and various major surgical complications compromising visual outcome.
Methods: This study of 78 patients was undertaken to know the incidence and severity of IFIS as well as to predict its occurrence by observing maximum pupil dilation achieved preoperatively.
Results: It was observed that majority of patients on tamsulosin dilated poorly and severe IFIS occurred in those with pupil dilation of 5 mm or less after putting mydriatic eye drops preoperatively.
Conclusions: It was concluded that if IFIS was predicted and necessary precautions taken, postoperative complications can be reduced significantly with improved visual outcome.
References
Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 2005;31:664-73.
Skorin L, Larsen K. A newly identified miotic syndrome associated with the use of a popular prostate drug. Clin Surg Ophthalmol. 2005;23(4):122-8.
Chang DF. Intraoperative floppy iris syndrome. In: Agarwal A (ed): Phaco Nightmares: Conquering Cataract Catastrophes. Thorofare, NJ: Slack, Inc.; 2006:131-9.
Chadha V, Borooah S, Tey A. Floppy iris behavior during cataract surgery: associations and variations. Br J Ophthalmol. 2007 Jan;91(1):40-2.
Chang DF, Osher RH, Wang L, Koch DD. Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmol. 2007 May;114(5):957-64.
Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, Nichamin LD, et al. ASCRS Cataract Clinical Committee. Clinical experience with intraoperative floppy-iris syndrome. Results of the 2008 ASCRS member survey. J Cataract Refract Surg. 2008;34:1201-9.
Prata TS, Palmiero PM, Angelilli A. Iris Morphologic changes related to alpha one adrenergic Receptor antagonists: implications for floppy iris syndrome. Ophthalmol. 2009;116:877-88.
Santaella RM, Destafeno JJ, Stinnett SS. The effect of alpha 1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy. Ophthalmol. 2010 Sep;117(9):1743-9.
Calotti F, Steen D. Labetolol causing intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007 Jan;33(1):170-1.
Fine IH, Dworetzky J, Hoffman RS, Packer M. Range of drugs associated with IFIS. J Cataract Refract Surg. 2009 Jan;35(1):202.
Cheung CM, Awan MA, Saudramouli S. Prevalence and clinical findings of tamsulosin-associated intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2006 Aug;32(8):1336-9.
Neff KD, Sandoval HP, Fernández de Castro LE, Nowacki AS, Vroman DT, Solomon KD. Factors associated with intraoperative floppy iris syndrome. Ophthalmol. 2009;116:658-63.
Casuccio A, Cillino G, Pavone C, Spitale E, Cillino S. Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2011;37:1447-54.
Pärssineu O, Leppäneu E, Keski-Rahkonen P. Influence of tamsulosin on the iris and its implications for cataract surgery. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3766-71.
Bendel RE, Phillips MB. Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin. J Cataract Refract Surg. 2006 Oct;32(10):1603-5
Goyal S, Dalela D, Goyal NK, Chawla S, Dhesi R, Kamboj B, et al. Intraoperative floppy iris syndrome in Indian population: a prospective study on incidence, risk factors, and impact on operative performance. Ind J Ophthalmol. 2014;62(8):870-5.
